IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BORRONI, BARBARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.404
AS - Asia 16.597
EU - Europa 12.687
SA - Sud America 3.855
Continente sconosciuto - Info sul continente non disponibili 843
AF - Africa 420
OC - Oceania 42
Totale 66.848
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.697
SG - Singapore 5.497
CN - Cina 5.229
BR - Brasile 3.184
UA - Ucraina 2.453
DE - Germania 2.425
IT - Italia 2.205
HK - Hong Kong 2.058
VN - Vietnam 1.197
GB - Regno Unito 930
FR - Francia 921
PL - Polonia 875
RU - Federazione Russa 829
FI - Finlandia 819
BD - Bangladesh 802
TR - Turchia 527
IE - Irlanda 452
IN - India 391
CA - Canada 308
AR - Argentina 266
MX - Messico 177
NL - Olanda 148
SE - Svezia 135
IQ - Iraq 133
ID - Indonesia 121
EC - Ecuador 108
ZA - Sudafrica 108
BE - Belgio 103
JP - Giappone 93
AT - Austria 89
ES - Italia 78
CO - Colombia 76
PK - Pakistan 75
NG - Nigeria 64
VE - Venezuela 64
CZ - Repubblica Ceca 62
MA - Marocco 62
SA - Arabia Saudita 61
PY - Paraguay 55
UZ - Uzbekistan 53
CL - Cile 48
JM - Giamaica 41
AU - Australia 38
CR - Costa Rica 34
KE - Kenya 34
KR - Corea 32
PH - Filippine 29
HN - Honduras 28
EG - Egitto 27
IL - Israele 27
TN - Tunisia 27
LT - Lituania 26
AE - Emirati Arabi Uniti 24
NP - Nepal 24
JO - Giordania 23
EU - Europa 22
IR - Iran 21
KZ - Kazakistan 21
PE - Perù 21
DO - Repubblica Dominicana 20
GT - Guatemala 20
MY - Malesia 20
UY - Uruguay 19
TH - Thailandia 18
AZ - Azerbaigian 17
DZ - Algeria 17
LB - Libano 17
MU - Mauritius 17
RO - Romania 16
TW - Taiwan 15
BG - Bulgaria 14
CH - Svizzera 13
ET - Etiopia 13
TT - Trinidad e Tobago 13
SV - El Salvador 12
SN - Senegal 11
BH - Bahrain 10
BY - Bielorussia 10
NI - Nicaragua 10
PS - Palestinian Territory 10
BO - Bolivia 9
LV - Lettonia 9
PA - Panama 9
CI - Costa d'Avorio 8
EE - Estonia 8
XK - ???statistics.table.value.countryCode.XK??? 8
AL - Albania 7
BB - Barbados 7
HR - Croazia 7
LY - Libia 7
RS - Serbia 7
DK - Danimarca 6
HU - Ungheria 6
KW - Kuwait 6
PT - Portogallo 6
AM - Armenia 5
GD - Grenada 5
KG - Kirghizistan 5
NO - Norvegia 5
OM - Oman 5
Totale 65.924
Salva come PNG Salva come JPEG
Città #
Fairfield 3.708
Singapore 2.893
Woodbridge 2.818
Ashburn 2.665
Hong Kong 2.050
Houston 1.923
Jacksonville 1.776
Seattle 1.474
Cambridge 1.348
Ann Arbor 1.322
San Jose 1.283
Wilmington 1.247
The Dalles 1.050
Beijing 1.003
Warsaw 863
Princeton 790
New York 772
Council Bluffs 710
Nanjing 645
Chandler 628
Los Angeles 507
Lauterbourg 486
Helsinki 450
Dublin 448
Dallas 445
Ho Chi Minh City 445
Istanbul 430
Columbus 395
Milan 340
Dearborn 327
Munich 283
São Paulo 277
Buffalo 265
Nanchang 247
Moscow 239
Hanoi 238
Des Moines 235
Brescia 232
Redondo Beach 198
Santa Clara 185
Chicago 179
Shenyang 178
San Diego 176
Changsha 174
Shanghai 160
San Francisco 145
Frankfurt am Main 140
Hebei 135
Jinan 130
London 121
Rome 117
Tianjin 112
Nuremberg 111
Rio de Janeiro 106
Turku 106
Jiaxing 98
Phoenix 97
Brussels 95
Lancaster 95
Orem 95
Brooklyn 94
Belo Horizonte 85
Kunming 84
Toronto 80
Boardman 77
Tokyo 76
Montreal 75
Hangzhou 70
Denver 68
Guangzhou 66
Atlanta 60
Abuja 59
Mexico City 55
Zhengzhou 55
Verona 54
Haiphong 52
Johannesburg 52
Naples 51
Ningbo 50
Chennai 49
Norwalk 49
Tashkent 49
Brasília 45
San Mateo 45
Curitiba 44
Dhaka 44
Charlotte 43
Porto Alegre 43
Baghdad 42
Manchester 42
Nürnberg 42
Quito 42
Mumbai 41
Stockholm 41
Amsterdam 40
Da Nang 38
Vienna 38
Boston 37
Taizhou 37
Bologna 36
Totale 42.360
Salva come PNG Salva come JPEG
Nome #
[(11)C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis 430
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 362
"Alien face" in corticobasal degeneration syndrome: Extending clinical features [2] 331
Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence. 326
The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer's disease. 285
White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia. 272
A complicated case of intracranial hypotension: Diagnostic and management strategies 268
COVID-19 impact on consecutive neurological patients admitted to the emergency department 266
Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD. 265
Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease. 261
Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia. 256
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 240
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. 234
Altered brain metabolic connectivity at multiscale level in early Parkinson's disease 233
Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators 231
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 231
QT dispersion and heart rate variability abnormalities in Alzheimer's disease and in mild cognitive impairment. 228
CSF Alzheimer's disease-like pattern in Corticobasal Syndrome: evidence for a distinct disorder. 228
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 227
Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment 217
Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration 215
Mendelian forms of disease and age at onset affect survival in frontotemporal dementia 211
Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging 210
Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. 209
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 209
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 209
Increased prevalence of silent myocardial ischaemia and severe ventricular arrhythmias in untreated patients with Alzheimer's disease and mild cognitive impairment without overt coronary artery disease 207
A case report: doctor, my daughter has Alzheimer's disease. 204
Extrapyramidal symptoms in Frontotemporal Dementia: prevalence and clinical correlations 201
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 201
Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation 201
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease 195
Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study. 194
A complicated case of intracranial hypotension: diagnostic and management strategies. 192
A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. 192
Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia. 192
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 191
EEG and granular osmiophilic elements in early-onset Alzheimer's disease. 188
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 188
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 188
TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. 186
Functional and structural changes in Alzheimer’s disease and Mild Cognitive Impairment. Possible predictive role of QT Dispersion and Heart Rate Variability analisys 185
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 185
The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease 185
A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease 184
Education plays a different role in Frontotemporal Dementia and Alzheimer's disease 183
Autoimmunity and frontotemporal dementia 182
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure 182
Revisiting brain reserve hypothesis in frontotemporal dementia: evidence from a brain perfusion study. 181
Is early-onset clinicallydifferent from late-onset frontotemporal dementia? 181
Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy 180
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 180
Functional correlates of Apolipoprotein E genotype in Frontotemporal Lobar Degeneration 177
Acombination of CSF tau ratio and midsaggital midbraintopons atrophy for the earlydiagnosis of progressive supranuclear palsy 175
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 175
Treatment of primary progressive aphasias by transcranial direct current stimulation combined with language training 174
Metodo di generazione di un indice diagnostico per malattia di alzheimer, apparato elettronico di implementazione del metodo e sistema 174
Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia 174
FOXP2, APOE, and PRNP: new modulators in primary progressive aphasia. 173
Prefrontal cortex rTMS enhances action naming in Progressive Non-Fluent Aphasia 172
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD 172
Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidalsyndromes 171
Subcortical and deep cortical atrophy in Frontotemporal Lobar Degeneration. 170
Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study 170
Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38. 170
A PCR-based protocol to accurately size C9orf72 intermediate-length alleles. 170
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 169
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 169
Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates. 168
Vascular risk factors and cognition in Parkinson's disease 168
Cardiac arrhythmias and silent myocardial ischaemia in Mild Cognitive Impairment and Alzheimer Disease 167
Serum C-Peptide, Visfatin, Resistin, and Ghrelin are Altered in Sporadic and GRN-Associated Frontotemporal Lobar Degeneration 167
Enhancing theory of mind in behavioural variant frontotemporal dementia with transcranial direct current stimulation 167
Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease. 165
Two Sequential Tc-99m ECD SPECT Studies in a Case of Sporadic Creutzfeldt–Jakob Disease Confirmed at Autopsy 165
Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype. 165
Sensitivity and specificity of transcranial magnetic stimulation for differential diagnosis of Alzheimer’s disease and frontotemporal dementia 164
ELOVL5 mutations cause spinocerebellar ataxia 38. 163
Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations. 161
Cerebellar transcranial direct current stimulation in patients with ataxia: A double-blind, randomized, sham-controlled study. 161
Alterazioni del flusso ematico cerebrale nella Malattia di Alzheimer 161
Dementia, delusions and seizures: storage disease or genetic AD? 159
The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is not significantly correlated to Transient Global Amnesia: preliminary results of an on-going study in Brescia Province, Italy. 159
Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort. 159
Iron in Frontotemporal Lobar Degeneration: A New Subcortical Pathological Pathway? 159
New insights into the genetic etiology of Alzheimer’s disease and related dementias 158
Cardiovascular structural and functional changes in Mild Cognitive Impairment and Alzheimer Disease.Potential predictive role of QT Dispersion and Heart Rate Variability Analysis 157
APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk 156
The Speech and Language FOXP2 GeneModulates the Phenotype of Frontotemporal Lobar Degeneration 156
A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia. 156
Frontotemporal dementia and its subtypes: A genome-wide association study 155
Clinical, biological, and imaging features of monogenic Alzheimer's Disease. 155
Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin. 155
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 155
Natural history and predictors of survival in progressive supranuclear palsy. 155
Pattern ofbehavioral disturbances in corticobasal degeneration syndrome and progressivesupranuclear palsy 155
Beyond cognitive reserve: behavioural reserve hypothesis in Frontotemporal Dementia. 154
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of Parkinson’s disease and dementia with Lewy bodies, 154
Behavioral dimensions and acetylcholinesterase inhibitor-related effect in Alzheimer disease over time: a latent trajectory modeling. 153
A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD. 153
Totale 19.442
Salva come PNG Salva come JPEG
Categoria #
all - tutte 327.500
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 327.500
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.419 0 0 69 148 29 162 228 236 190 416 280 661
2022/20232.442 448 115 63 152 155 675 24 171 273 71 171 124
2023/20243.243 169 72 289 209 107 499 111 117 950 65 58 597
2024/20259.056 79 50 88 1.262 1.015 729 824 255 934 775 1.835 1.210
2025/202620.319 1.720 2.801 1.735 3.089 1.415 1.213 2.692 806 1.238 1.610 1.266 734
2026/20272.717 1.009 1.059 649 0 0 0 0 0 0 0 0 0
Totale 66.848